TrimRx's Blog

Introduction Trulicity® (dulaglutide) is Eli Lilly’s once-weekly GLP-1 injection, FDA-approved in 2014 for type 2 diabetes and approved in 2020 for cardiovascular risk reduction…

Introduction Trulicity® (dulaglutide) is Eli Lilly’s once-weekly GLP-1 injection, FDA-approved in 2014 for type 2 diabetes and approved in 2020 for cardiovascular risk reduction…

Introduction Trulicity® (dulaglutide) is Eli Lilly’s once-weekly GLP-1 injection, FDA-approved in 2014 for type 2 diabetes and approved in 2020 for cardiovascular risk reduction…

Introduction Trulicity® (dulaglutide) is Eli Lilly’s once-weekly GLP-1 injection, FDA-approved in 2014 for type 2 diabetes and approved in 2020 for cardiovascular risk reduction…

Introduction Trulicity® (dulaglutide) is Eli Lilly’s once-weekly GLP-1 injection, FDA-approved in 2014 for type 2 diabetes and approved in 2020 for cardiovascular risk reduction…

Pricing comparisons between TrimRx and ShedRx come down to specific dose tier, current promotional offers, and any add-ons each platform bundles.

TrimRx and ShedRx both operate as GLP-1-focused telehealth platforms prescribing compounded semaglutide and tirzepatide.

Ro Body and TrimRx use very different pricing models, which makes a head-to-head cost comparison less straightforward than it looks.

Ro Body (the weight-management arm of Ro, formerly Roman) and TrimRx are two of the most-searched GLP-1 telehealth options in 2026.